BioMimetic Pharmaceuticals, Inc. to Introduce Augmatrix™ Biocomposite Bone Graft Product Line at American Academy of Orthopaedic Surgeons
2/8/2012 7:40:24 AM
More...
|
BioMimetic Pharmaceuticals, Inc. to Present at the Jefferies and Co. Global Healthcare Conference
6/6/2011 10:15:15 AM
More...
|
BioMimetic Pharmaceuticals, Inc.'s Bone Product Trial Disappoints
10/14/2009 7:51:55 AM
More...
|
BioMimetic Pharmaceuticals, Inc. Reports Promising Clinical Results Using Augment Injectable Bone Graft to Treat Distal Radius Fractures
10/29/2008 8:45:07 AM
More...
|
BioMimetic Pharmaceuticals, Inc. Initiates Enrollment in E.U. Registration Trial for GEM OS(R)1Bone Graft
6/7/2007 12:27:59 PM
More...
|
The Week In Review: Big Week For IPOs
2/12/2007 1:48:53 PM
More...
|
The Day In Review: SuperGen, Inc. (SUPG) Drug Disappoints
4/26/2006 6:10:46 PM
More...
|
BioMimetic Therapeutics Initiates Clinical Trials With Novel Bio-Active Drug-Device Combination Bone Graft In Two Orthopedic Indications
3/20/2006 2:17:30 PM
More...
|
BioMimetic Therapeutics Files For $50 Million IPO
2/10/2006 10:24:08 AM
More...
|
BioMimetic Pharmaceuticals Inc. Raises $25.7 Million In Series C Financing
10/19/2005 5:12:04 PM
More...
|
|